46 related articles for article (PubMed ID: 1972136)
21. The role of autologous stem cell transplantation in the management of multiple myeloma.
Fermand JP; Brechignac S
Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
[TBL] [Abstract][Full Text] [Related]
22. [Stem cell supported high dose chemotherapy (HDCT) in primary treatment of advanced ovarian carcinoma].
Möbus V; von Schilling C; Kreienberg R; Wiesneth M; Bergmann L; Frickhofen N
Praxis (Bern 1994); 1999 Mar; 88(12):507-12. PubMed ID: 10235025
[TBL] [Abstract][Full Text] [Related]
23. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
[TBL] [Abstract][Full Text] [Related]
24. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
25. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of advanced ovarian cancer].
Hirabayashi K
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1856-63. PubMed ID: 2203316
[TBL] [Abstract][Full Text] [Related]
27. [Place of autologous and allogeneic hematopoietic stem cell transplantation in ovarian cancer].
Nayl B; Cabrespine-Faugeras A; Maliki Y; Bay JO
Bull Cancer; 2009 Dec; 96(12):1225-32. PubMed ID: 19939780
[TBL] [Abstract][Full Text] [Related]
28. [High-dose chemotherapy with autologous bone marrow transplantation or peripheral blood stem cell transplantation--testicular cancer].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1771-6. PubMed ID: 7574808
[TBL] [Abstract][Full Text] [Related]
29. Multiple cycles of high-dose chemotherapy for ovarian cancer.
Schilder RJ; Shea TC
Semin Oncol; 1998 Jun; 25(3):349-55. PubMed ID: 9633847
[TBL] [Abstract][Full Text] [Related]
30. High-dose chemotherapy with autologous stem cell support in advanced ovarian cancer.
Grénman SE; Rantanen VT; Salmi TA
Ann Med; 1996 Apr; 28(2):151-8. PubMed ID: 8732644
[TBL] [Abstract][Full Text] [Related]
31. Role of chemotherapy dose intensification in the treatment of advanced ovarian cancer.
Fennelly D; Schneider J
Oncology (Williston Park); 1995 Oct; 9(10):911-21; discussion 922, 924, 926. PubMed ID: 8573476
[TBL] [Abstract][Full Text] [Related]
32. [Therapeutic concept in ovarian cancer].
Rath W; Meden H
Med Klin (Munich); 1991 May; 86(5):263-8. PubMed ID: 1875867
[No Abstract] [Full Text] [Related]
33. High-dose chemotherapy for the treatment of breast and ovarian cancer.
Cagnoni PJ; Shpall EJ
Curr Opin Oncol; 1997 Mar; 9(2):122-5. PubMed ID: 9161788
[TBL] [Abstract][Full Text] [Related]
34. The role of high-dose chemotherapy with hematopoietic stem cell support in the treatment of patients with epithelial ovarian carcinoma.
Hussein AM
Cancer Invest; 1997; 15(3):288-95. PubMed ID: 9171864
[No Abstract] [Full Text] [Related]
35. Remaining controversies in the upfront management of advanced ovarian cancer.
Mano MS; Awada A; Minisini A; Atalay G; Lago LD; Cardoso F; Piccart M
Int J Gynecol Cancer; 2004; 14(5):707-20. PubMed ID: 15361178
[TBL] [Abstract][Full Text] [Related]
36. High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults.
Pedrazzoli P; Ledermann JA; Lotz JP; Leyvraz S; Aglietta M; Rosti G; Champion KM; Secondino S; Selle F; Ketterer N; Grignani G; Siena S; Demirer T;
Ann Oncol; 2006 Oct; 17(10):1479-88. PubMed ID: 16547069
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of ovarian cancer. Literature review].
Collette M; Lemaire M; Dohogne A; Closon MT
Rev Med Liege; 1993 Oct; 48(10):558-68. PubMed ID: 8248677
[No Abstract] [Full Text] [Related]
38. High dose chemotherapeutic strategies in the treatment of epithelial ovarian carcinoma.
McAfee SL; Seiden MV
Curr Opin Obstet Gynecol; 1999 Feb; 11(1):17-21. PubMed ID: 10047958
[TBL] [Abstract][Full Text] [Related]
39. Prognostic indices in ovarian cancer. Their significance in treatment planning.
Swenerton KD
Acta Obstet Gynecol Scand Suppl; 1992; 155():67-74. PubMed ID: 1502892
[TBL] [Abstract][Full Text] [Related]
40. Ovarian cancer: state of the art and future directions.
Awada A; Klastersky J
Eur J Gynaecol Oncol; 2004; 25(6):673-6. PubMed ID: 15597841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
